Comparison of the time course of morphine's analgesic and immunologic effects

被引:38
作者
Nelson, CJ
Dykstra, LA
Lysle, DT
机构
[1] Department of Psychology, Univ. of N. Carolina at Chapel Hill, Chapel Hill, NC
[2] Department of Psychology, Davie Hall CB 3270, Univ. of N. Carolina at Chapel Hill, Chapel Hill
关键词
PERIAQUEDUCTAL GRAY; IMMUNE STATUS; INVOLVEMENT; NALTREXONE; IMMUNOSUPPRESSION; MICE; CELL;
D O I
10.1097/00000539-199709000-00024
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Morphine, an opioid analgesic commonly prescribed and abused, produces immune-altering effects. Whether morphine's antinociceptive and immunologic effects occur concurrently is unknown. Therefore, we investigated the time course of morphine's immunologic and antinociceptive effects. Rats were given a 15 mg/kg morphine injection (subcutaneously), and experimental assessments were taken at 30 min, 1 h, 2 h, 6 h, 12 h, and 24 h after treatment. Immune measures included natural killer (NK) cell activity, proliferation of splenic T and B lymphocytes, and cytokine production. Antinociception was assessed by using the tail withdrawal assay. Results show that morphine's immunomodulatory effects on NK cell activity begin within 30 min, continue for at least 12 h, and return to control values by 24 h. In contrast, proliferation of splenic T and B cells and interferon-gamma production are not altered within 30 min; maximal suppression occurs at 1 h, and recovery begins within 2 h. In all immune measures, therefore, maximal suppression is present at the 1-h time point, and recovery is complete within 24 h. Morphine induces antinociception 30 min to 2 h after drug administration; recovery is complete within 6 h. These results suggest the possibility that different mechanisms modulate morphine's immunologic and analgesic effects. Implications: Acute morphine treatment in rats produces immune alterations and antinociception. Although there are slight differences in morphine's maximal immunological and antinociceptive effects, morphine suppresses immune status at time points concordant with its antinociceptive effects. These effects should be considered when administering morphine to patients whose systems are immunocompromised.
引用
收藏
页码:620 / 626
页数:7
相关论文
共 16 条
  • [1] MORPHINE-INHIBITION OF LYMPHOCYTE ACTIVITY IS MEDIATED BY AN OPIOID DEPENDENT MECHANISM
    BAYER, BM
    DAUSSIN, S
    HERNANDEZ, M
    IRVIN, L
    [J]. NEUROPHARMACOLOGY, 1990, 29 (04) : 369 - 374
  • [2] DISTINCTION BETWEEN THE INVITRO AND INVIVO INHIBITORY EFFECTS OF MORPHINE ON LYMPHOCYTE-PROLIFERATION BASED ON AGONIST SENSITIVITY AND NALTREXONE REVERSIBILITY
    BAYER, BM
    GASTONGUAY, MR
    HERNANDEZ, MC
    [J]. IMMUNOPHARMACOLOGY, 1992, 23 (02): : 117 - 124
  • [3] BEILIN B, 1989, BRAIN BEHAV IMMUN, V2, P129
  • [4] CARR DJJ, 1994, J PHARMACOL EXP THER, V269, P693
  • [5] Fecho K, 1996, J PHARMACOL EXP THER, V277, P633
  • [6] FECHO K, 1993, J PHARMACOL EXP THER, V265, P1079
  • [7] DURATION OF INTERFERON INHIBITION FOLLOWING SINGLE AND MULTIPLE INJECTIONS OF MORPHINE
    GEBER, WF
    LEFKOWITZ, SS
    HUNG, CY
    [J]. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH, 1977, 2 (03): : 577 - 582
  • [8] HERNANDEZ MC, 1993, J PHARMACOL EXP THER, V267, P1336
  • [9] CELL AND RECEPTOR REQUIREMENTS FOR STREPTOCOCCAL PYROGENIC EXOTOXIN T-CELL MITOGENICITY
    LEONARD, BAB
    LEE, PK
    JENKINS, MK
    SCHLIEVERT, PM
    [J]. INFECTION AND IMMUNITY, 1991, 59 (03) : 1210 - 1214
  • [10] Lysle DT, 1996, J PHARMACOL EXP THER, V277, P1533